Clinical study of combination of Helicobacter pylori eradication therapy and ingestion of bifidobacteria-fermented milk
Not Applicable
- Conditions
- Helicobacter pylori infection
- Registration Number
- JPRN-UMIN000008834
- Lead Sponsor
- Medical Station Clinic Aisei Hospital, Ueno Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Subjects who are allergic to lactobacillus-fermented milk (2)Subjects with drug allergy (3)Subjects treated with proton pump inhibitor therapy one month before the screening test (4)Subjects treated with H. pylori eradication therapy (5)Subjects with bronchial asthma (6)Subjects with severe liver disease, renal dysfunction, and heart disease (7)Subjects judged as unsuitable for this study based on the results of clinical examination (8)Subjects who participate in other clinical trials (9)Subjects who are pregnant or lactating, or intending to become pregnant during the study (10)Subjects judged as unsuitable by the doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rea breath test H. pylori stool antigen H. pylori IgG antibody Pepsinogen I Pepsinogen II Pepsinogen I/II Gastrin intestinal flora Intestinal organic acids/metabolite GSRS FSSG ROME III FGID POMS short version
- Secondary Outcome Measures
Name Time Method